Navigation Links
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
Date:8/3/2009

Cell: (609) 647-8195 Sramaswa@its.jnj.com Investors Louise Mehrotra: (732) 524-6491 Johnson & Johnson Lesley Fishman: (732) 524-3922 Johnson & Johnson

References

    (1) Keith SJ, Kanke JM. Journal of Clinical Psychiatry 2003; 64:1308-15
    (2) Robinson D, Woerner MG, Alvir JM, et al. Predictors of relapse
    following response from a first episode of schizophrenia or
    Schizoaffective Disorder. Archives of General Psychiatry 1999; 56:241-247
    (3) Kane, JM. Review of Treatments That Can Ameliorate Nonadherence in
    Patients With Schizophrenia. Journal of Clinical Psychiatry 2006;
    67(suppl 5):9-14
    (4) Wyatt, RJ. Neuroleptics and the natural course of schizophrenia.
    Schizophrenia Bulletin 1991; 17:325-51


'/>"/>
SOURCE Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skins Natural Moisture
2. Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
3. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
4. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
5. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
6. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
7. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
8. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
9. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
10. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
11. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 2014 Luoxis Diagnostics, Inc. , ... (NYSE MKT: AMPE), today announced an upcoming presentation ... the American Academy of Surgical Trauma (AAST) and ... Philadelphia, Pennsylvania that will be ... results from a recently completed five-year prospective clinical ...
(Date:8/18/2014)... Mass. and NAGOYA, Japan ... (NYSE: BSX ) and ASAHI INTECC (Securities ... and Nagoya Stock Exchange) have formalized plans to develop ... joint project focuses on creating a device intended to ... The FFR market is an emerging field in interventional ...
(Date:8/18/2014)... , Aug. 18, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p01597713/Bioseparation-Systems-for-Global-Biopharmaceutical-Markets.html ... into three types: chromatography, membranes/filters and centrifuges. ... increasing and fueling growth of the global ...
Breaking Medicine Technology:Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 2Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 4Bioseparation Systems for Global Biopharmaceutical Markets 2Bioseparation Systems for Global Biopharmaceutical Markets 3Bioseparation Systems for Global Biopharmaceutical Markets 4Bioseparation Systems for Global Biopharmaceutical Markets 5Bioseparation Systems for Global Biopharmaceutical Markets 6Bioseparation Systems for Global Biopharmaceutical Markets 7Bioseparation Systems for Global Biopharmaceutical Markets 8Bioseparation Systems for Global Biopharmaceutical Markets 9Bioseparation Systems for Global Biopharmaceutical Markets 10Bioseparation Systems for Global Biopharmaceutical Markets 11Bioseparation Systems for Global Biopharmaceutical Markets 12
... Anthem Blue Cross and Blue Shield in ... transparency initiative beyond major metro areas into the ... and everywhere in between can now access Anthem ... cost information for 59 specific medical procedures performed ...
... 2010 STAAR Surgical Company (Nasdaq: STAA ... invasive ophthalmic products, today reported results for the third ... grew 6% to $13.2 million reflecting core product (IOLs ... decrease in defocused product revenue as compared to the ...
Cached Medicine Technology:Anthem Blue Cross Blue Shield Introduces Cost Disclosure Tool Throughout Colorado 2Anthem Blue Cross Blue Shield Introduces Cost Disclosure Tool Throughout Colorado 3STAAR Surgical Reports Continued Double Digit Core Revenue Growth 2STAAR Surgical Reports Continued Double Digit Core Revenue Growth 3STAAR Surgical Reports Continued Double Digit Core Revenue Growth 4STAAR Surgical Reports Continued Double Digit Core Revenue Growth 5STAAR Surgical Reports Continued Double Digit Core Revenue Growth 6STAAR Surgical Reports Continued Double Digit Core Revenue Growth 7STAAR Surgical Reports Continued Double Digit Core Revenue Growth 8STAAR Surgical Reports Continued Double Digit Core Revenue Growth 9STAAR Surgical Reports Continued Double Digit Core Revenue Growth 10STAAR Surgical Reports Continued Double Digit Core Revenue Growth 11STAAR Surgical Reports Continued Double Digit Core Revenue Growth 12STAAR Surgical Reports Continued Double Digit Core Revenue Growth 13STAAR Surgical Reports Continued Double Digit Core Revenue Growth 14STAAR Surgical Reports Continued Double Digit Core Revenue Growth 15STAAR Surgical Reports Continued Double Digit Core Revenue Growth 16STAAR Surgical Reports Continued Double Digit Core Revenue Growth 17
(Date:8/19/2014)... Kentucky Markey Cancer Center researchers will provide a simple, free ... require testing for a genetic mutation. , Gliomas a ... are the most common and deadly form of brain ... brain cancer cases. In some of these cases, patients have ... mutation and patients who have this tend to survive ...
(Date:8/19/2014)... Hartford/VA Scholars Program has selected three geriatric ... provides career development and mentorship for projects that ... veterans, but for all older adults. , The ... physical activity among veterans, transitions from VA nursing ... disorder in older veterans. The Hartford/VA Geriatric Scholars ...
(Date:8/19/2014)... 2014 United Benefit Advisors (UBA), ... is pleased to announce Sihle Insurance Group as ... provides a single solution for insurance, financial services, ... needs. With a focus on commercial and personal ... insurance solutions, and payroll services, they are able ...
(Date:8/19/2014)... Utah (PRWEB) August 19, 2014 ... Solution, published a new guide on compliance and ... Benefits, small businesses want to offer employee health ... insurance is unsustainable. Additionally, there are new advantages ... guaranteed-issue, and lower costs. , The new ...
(Date:8/19/2014)... Respected Dallas Plastic Surgeon ... nationwide to feature one of the most advanced ... UltraShape. UltraShape uses ultrasound waves to selectively breakdown ... , The UltraShape System, by Syneron Medical, is ... targets subcutaneous fat, while keeping the surrounding skin ...
Breaking Medicine News(10 mins):Health News:United Benefit Advisors Welcomes New Partner Firm Sihle Insurance Group 2Health News:United Benefit Advisors Welcomes New Partner Firm Sihle Insurance Group 3Health News:Dallas Plastic Surgeon Dr. Benjamin Bassichis is Among the First to Offer UltraShape for Non-Surgical Liposuction 2Health News:Dallas Plastic Surgeon Dr. Benjamin Bassichis is Among the First to Offer UltraShape for Non-Surgical Liposuction 3
... Five former directors of the Population and Reproductive Health ... (USAID) today urged the new Obama administration to move ... . The former directors issued a joint report, ... Assistance, as Barack Obama takes office as president. ...
... K. Shinseki took the oath of office today as ... leadership of the Department of Veterans Affairs following Tuesday,s ... from my first day in office is to make ... focused on the Nation,s Veterans as its clients," Shinseki ...
... 21 The following statement can be attributed ... BlueCross:"Capital BlueCross has consistently said two things: We ... other merger. But we have urged public policy ... this proposed merger without conditions, because without conditions ...
... low levels of sexual desire, often as a result of ... physical symptoms such as back pain and memory problems than ... new study by researchers at the University of North Carolina ... study, published recently as an online early view article in ...
... history was made 10 years ago, greatly impacting the ... when a team of surgeons performed the first hand ... procedure, also called composite tissue allotransplantation, criticized by some ... in the world of organ transplantation, has continued to ...
... IDEXX Laboratories, Inc. (Nasdaq: IDXX ), has scheduled ... results for Friday, January 30, at approximately 7:00 a.m. (eastern). ... 9:00 a.m. (eastern) on that day. Individuals can access a ... the IDEXX Web site, www.idexx.com . An archived edition ...
Cached Medicine News:Health News:Five Former USAID Officials Ask Obama for Leadership on Family Planning 2Health News:Shinseki Sworn In, Vows 21st Century Service to Veterans 2Health News:Capital Blue Cross Issues Statement on Withdrawal of Merger 2Health News:UNC study: Postmenopausal women's loss of sexual desire affects health, quality of life 2Health News:Hand Transplantation Marks Historical 10-Year Milestone 2Health News:Hand Transplantation Marks Historical 10-Year Milestone 3Health News:Hand Transplantation Marks Historical 10-Year Milestone 4
... The Awaya stereo test was developed to ... Awaya Stereo test employs the more reliable ... eye. It is not dependent on polarizing spectacles ... first target is an attractive image of a ...
... is designed to assist patients with red-green color ... filter cuts off wavelengths shorter than 582 nm ... of their most difficult color distinctions. A color ... determine whether a color is in the longer ...
Features a twist-on backswitch, with a diffused, cobalt blue light beam....
Heavy duty, all purpose illuminator available in blue and green. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentra...
Medicine Products: